Cellectis (CLLS) Intangibles (2013 - 2026)
Cellectis' (CLLS) quarterly Intangibles came in at $221000.0 in Q1 2026, down 8.68% year-on-year from $242000.0 in Q1 2025, and down 58.69% quarter-over-quarter from $535000.0 in Q4 2025.
Cellectis (CLLS) Intangibles (2013 - 2026) Analysis & Trends
Cellectis' Intangibles history runs 14 years deep, the most recent figure standing at $221000.0 for Q1 2026.
- On a quarterly basis, Intangibles fell 8.68% year-over-year to $221000.0 in Q1 2026; TTM through Mar 2026 was $221000.0, a 8.68% decrease from a year earlier, with the FY2025 full-year figure at $535000.0, down 52.06% from the prior year.
- Intangibles fell to $221000.0 in Q1 2026 per CLLS's latest filing, from $535000.0 in the prior quarter.
- Across five years, Intangibles topped out at $1.7 million in Q1 2022 and bottomed at $221000.0 in Q1 2026.
- The 5-year median for Intangibles is $695000.0 (2023), against an average of $846176.5.
- Biggest YoY gain for Intangibles was 76.57% in 2025; the steepest drop was 64.25% in 2025.
- Year by year, Intangibles stood at $718000.0 in 2022, then retreated by 6.55% to $671000.0 in 2023, then soared by 66.32% to $1.1 million in 2024, then slumped by 52.06% to $535000.0 in 2025, then plunged by 58.69% to $221000.0 in 2026.
- Per Business Quant, the three latest CLLS Intangibles figures stand at $221000.0 (Q1 2026), $535000.0 (Q4 2025), and $845000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | 221,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221,000.00 |
| Dec 31, 2025 | 535,000.00 |
| Sep 30, 2025 | 845,000.00 |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 242,000.00 |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | 691,000.00 |
| Jun 30, 2024 | 653,000.00 |
| Mar 31, 2024 | 677,000.00 |
| Dec 31, 2023 | 671,000.00 |
| Sep 30, 2023 | 662,000.00 |
| Jun 30, 2023 | 695,000.00 |
| Mar 31, 2023 | 713,000.00 |
| Dec 31, 2022 | 718,000.00 |
| Sep 30, 2022 | 1.51 Mn |
| Jun 30, 2022 | 1.58 Mn |
| Mar 31, 2022 | 1.70 Mn |
| Dec 31, 2021 | 1.85 Mn |
| Sep 30, 2021 | 2.55 Mn |
| Jun 30, 2021 | 1.58 Mn |